Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
Same author

Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study.

medRxiv : the preprint server for health sciences·2026
Same author

Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models.

NPJ precision oncology·2026
Same author

Proteomic and phosphoproteomic signatures of disease progression in unmutated IGHV chronic lymphocytic leukemia.

Clinical proteomics·2026
Same author

Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals.

medRxiv : the preprint server for health sciences·2026
Same author

Germline Variants in Chronic Pancreatitis-Associated Genes and Risk of Pancreatic Ductal Adenocarcinoma.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Related Experiment Video

Updated: May 22, 2025

Single-cell RNA Sequencing and Analysis of Human Pancreatic Islets
11:34

Single-cell RNA Sequencing and Analysis of Human Pancreatic Islets

Published on: July 18, 2019

16.3K

Variation in bulk RNA-seq and estimated cell type proportion using deconvolution when comparing pancreatic cancer

Rick J Jansen1, Sarah A Munro2, Samuel O Antwi3

  • 1Masonic Cancer Center, University of Minnesota, Minneapolis, MN.

Medrxiv : the Preprint Server for Health Sciences
|May 19, 2025
PubMed
Summary

Tumor gene expression analysis may vary between patient samples, impacting personalized cancer treatment. Multiple tumor biopsies might be necessary for accurate genomic interpretation and effective treatment planning.

More Related Videos

Pancreatic Tissue Dissection to Isolate Viable Single Cells
08:04

Pancreatic Tissue Dissection to Isolate Viable Single Cells

Published on: May 26, 2023

2.4K
Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues
10:12

Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues

Published on: January 10, 2019

18.4K

Related Experiment Videos

Last Updated: May 22, 2025

Single-cell RNA Sequencing and Analysis of Human Pancreatic Islets
11:34

Single-cell RNA Sequencing and Analysis of Human Pancreatic Islets

Published on: July 18, 2019

16.3K
Pancreatic Tissue Dissection to Isolate Viable Single Cells
08:04

Pancreatic Tissue Dissection to Isolate Viable Single Cells

Published on: May 26, 2023

2.4K
Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues
10:12

Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues

Published on: January 10, 2019

18.4K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Genomic data holds promise for personalized cancer treatment.
  • Intratumor genetic heterogeneity necessitates understanding variations within a tumor.
  • Assessing gene expression across multiple tumor samples is crucial for treatment strategy.

Purpose of the Study:

  • To investigate if tumor gene expression analysis interpretation varies between two specimens from the same patient.
  • To compare cell type proportions and gene expression reliability across paired tumor samples.

Main Methods:

  • Bulk RNA-sequencing was performed on FFPE samples from 16 patients.
  • Three deconvolution methods were used to compare cell type proportions.
  • Transcripts per million normalization and batch effect adjustment were applied for gene expression comparison.

Main Results:

  • Significant variations in average cell type proportions were observed for NK cells and macrophages between samples.
  • No significant differences in average expression were found for selected key pancreatic cancer genes.
  • Concordance in gene expression measurements varied, with substantial agreement only for JUN.

Conclusions:

  • Findings suggest that multiple tumor samples may be required for effective cancer treatment planning.
  • Differences in observed expression values could be attributed to varying cell type proportions.
  • Further studies are needed to confirm interpretations due to small sample size and different sequencing technologies.